Wuxi AppTec Co Ltd (WUXAY)
5.07
-0.38
(-6.97%)
USD |
OTCM |
May 17, 15:52
Wuxi AppTec SG&A Expense (Quarterly): 105.51M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 105.51M |
| December 31, 2023 | -124.27M |
| September 30, 2023 | 266.59M |
| June 30, 2023 | -36.10M |
| March 31, 2023 | 120.52M |
| December 31, 2022 | -131.65M |
| September 30, 2022 | 274.28M |
| June 30, 2022 | -8.982M |
| March 31, 2022 | 122.05M |
| December 31, 2021 | -84.03M |
| September 30, 2021 | 207.72M |
| June 30, 2021 | 3.61M |
| March 31, 2021 | 97.76M |
| December 31, 2020 | -93.22M |
| September 30, 2020 | 90.40M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0192M |
| March 31, 2020 | 69.26M |
| December 31, 2019 | -55.93M |
| September 30, 2019 | 67.96M |
| June 30, 2019 | 1.243M |
| March 31, 2019 | 59.22M |
| December 31, 2018 | -38.65M |
| September 30, 2018 | 61.78M |
| June 30, 2018 | -25.21M |
| March 31, 2018 | 42.91M |
| December 31, 2017 | -88.21M |
| September 30, 2017 | 49.91M |
| June 30, 2017 | 49.24M |
| March 31, 2017 | 48.07M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
-131.65M
Minimum
Dec 2022
274.28M
Maximum
Sep 2022
44.64M
Average
35.79M
Median
SG&A Expense (Quarterly) Benchmarks
| WuXi Biologics (Cayman) Inc | -- |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 11.57M |
| Zai Lab Ltd | 69.19M |
| Gracell Biotechnologies Inc (DELISTED) | 4.381M |